Totoritis MC - Search Results

1

Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.

DuPont HL, Petersen A, Zhao J, Mundt A, Jiang ZD, Miller S, Flores J, Shringarpure R, Moro L, Bagin RG, Ballard ED, Totoritis MC. DuPont HL, et al. Among authors: totoritis mc. J Travel Med. 2014 Nov-Dec;21(6):369-76. doi: 10.1111/jtm.12168. J Travel Med. 2014. PMID: 25345982 Free article. Clinical Trial.

2

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.

Riedl MA, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M; Study 1310 Investigators. Riedl MA, et al. Among authors: totoritis mc. Ann Allergy Asthma Immunol. 2014 Feb;112(2):163-169.e1. doi: 10.1016/j.anai.2013.12.004. Epub 2014 Jan 7. Ann Allergy Asthma Immunol. 2014. PMID: 24468257 Clinical Trial.

3

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.

Kalunian KC, Davis JC Jr, Merrill JT, Totoritis MC, Wofsy D; IDEC-131 Lupus Study Group. Kalunian KC, et al. Among authors: totoritis mc. Arthritis Rheum. 2002 Dec;46(12):3251-8. doi: 10.1002/art.10681. Arthritis Rheum. 2002. PMID: 12483729 Free article. Clinical Trial.

4

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Among authors: totoritis mc. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Free article. Clinical Trial.

5

Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus.

Davis JC Jr, Totoritis MC, Rosenberg J, Sklenar TA, Wofsy D. Davis JC Jr, et al. Among authors: totoritis mc. J Rheumatol. 2001 Jan;28(1):95-101. J Rheumatol. 2001. PMID: 11196549 Clinical Trial.

6

B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.

Shaw T, Quan J, Totoritis MC. Shaw T, et al. Among authors: totoritis mc. Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii55-9. doi: 10.1136/ard.62.suppl_2.ii55. Ann Rheum Dis. 2003. PMID: 14532151 Free PMC article. Review. No abstract available.

7

Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial.

Rosenwasser LJ, Busse WW, Lizambri RG, Olejnik TA, Totoritis MC. Rosenwasser LJ, et al. Among authors: totoritis mc. J Allergy Clin Immunol. 2003 Sep;112(3):563-70. doi: 10.1016/s0091-6749(03)01861-x. J Allergy Clin Immunol. 2003. PMID: 13679816 Clinical Trial.

8

Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis.

Gottlieb AB, Kang S, Linden KG, Lebwohl M, Menter A, Abdulghani AA, Goldfarb M, Chieffo N, Totoritis MC. Gottlieb AB, et al. Among authors: totoritis mc. Clin Immunol. 2004 Apr;111(1):28-37. doi: 10.1016/j.clim.2004.01.006. Clin Immunol. 2004. PMID: 15093549 Clinical Trial.

9

CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.

Mason U, Aldrich J, Breedveld F, Davis CB, Elliott M, Jackson M, Jorgensen C, Keystone E, Levy R, Tesser J, Totoritis M, Truneh A, Weisman M, Wiesenhutter C, Yocum D, Zhu J. Mason U, et al. J Rheumatol. 2002 Feb;29(2):220-9. J Rheumatol. 2002. PMID: 11838838 Clinical Trial.

10

Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody.

Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, Chaudhari U, Allen RS, Lizambri RG. Gottlieb AB, et al. Among authors: totoritis mc. J Am Acad Dermatol. 2002 Nov;47(5):692-700. doi: 10.1067/mjd.2002.124698. J Am Acad Dermatol. 2002. PMID: 12399760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters